Similar Papers

Paper Title
Journal
Date
Author
Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD2 receptor?
Katherine N Cahill
Journal of Allergy and Clinical Immunology | VOL. 149
Katherine N CahillKatherine N Cahill
15 Mar 2022
Biologics for chronic rhinosinusitis with nasal polyps (CRSwNP)
Glenis K Scadding ... Guy W Scadding
Journal of Allergy and Clinical Immunology | VOL. 149
Glenis K Scadding, et. al.Glenis K Scadding ... Guy W Scadding
06 Nov 2021
Reduction in healthcare resource use through 24 months following sinus surgery with steroid-eluting implants in chronic rhinosinusitis patients with and without nasal polyps: a real-world study
Veena Hoffman ... James E Kallman
Current Medical Research and Opinion | VOL. 39
Veena Hoffman, et. al.Veena Hoffman ... James E Kallman
05 Apr 2023
Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma
Claus Bachert ... Asif Khan
The Journal of Allergy and Clinical Immunology: In Practice | VOL. 7
Claus Bachert, et. al.Claus Bachert ... Asif Khan
27 Mar 2019
View more papers

More From: International Forum of Allergy & Rhinology

Paper Title
Journal
Date
Author
Superior Benefits of Combining Mepolizumab With Sinus Surgery Compared to Mepolizumab Alone: Results From a Randomised 6‐Month Trial
Anne‐Sophie Homøe ... Vibeke Backer
International Forum of Allergy & Rhinology | VOL. -
Anne‐Sophie Homøe, et. al.Anne‐Sophie Homøe ... Vibeke Backer
10 Mar 2025
-
-
International Forum of Allergy & Rhinology | VOL. 15
--
01 Mar 2025
Issue Information
-
International Forum of Allergy & Rhinology | VOL. 15
--
01 Mar 2025
-
-
International Forum of Allergy & Rhinology | VOL. 15
--
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.